Teen Driving Translation Study (NIH)
Launched by GINGER YANG · Jan 12, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Teen Driving Translation Study is looking to help young drivers, specifically those aged 16 or 17 who have recently received a traffic violation. The goal of this study is to improve safe driving behaviors by involving parents in the process. It focuses on understanding how well a new program works in both rural and urban areas, particularly for teens who are considered at high risk for getting into more trouble on the road. Researchers will also evaluate how cost-effective this program is.
To participate, teens need to be first-time offenders with a valid Ohio provisional driver's license and must have access to a vehicle made after 1996. They should also have a smartphone with Bluetooth capabilities. However, teens who have had previous traffic violations, cannot drive due to injury, or are in other specific situations may not be eligible. Participants can expect to engage in activities that will help them improve their driving skills, and their parents will be actively involved in the process. This study is currently recruiting participants, and it aims to provide valuable insights that could lead to safer driving practices for teens.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Teen must be 16 or 17 years old at the time of the moving-related violation
- • Teen must be a first-time offender and be found guilty of committing the violation
- • Teen must possess a valid Ohio provisional driver's license and proof of car insurance
- • Teen must have access to a vehicle with an On-board Diagnostics II system port (i.e., cars made after 1996) in which they are the primary driver
- • Teen must have a smart phone with Bluetooth capabilities
- Exclusion Criteria:
- • Teen is unable to drive due to injury, has a suspended driver's license, and/or car damage
- • Teen has previously received a traffic citation
- • Vehicle already has an in-vehicle driving feedback system installed
- • Teen has non-English speaking parents
- • Teen is currently enrolled in another driving-related study
- • Teen is a ward of the State
- • Adults unable to consent
- • Pregnant women
- • Prisoners
About Ginger Yang
Ginger Yang is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on developing novel therapeutic interventions, Ginger Yang collaborates with leading healthcare institutions and research organizations to conduct rigorous clinical trials. The organization prioritizes patient safety, ethical research practices, and scientific integrity, ensuring that all studies contribute meaningful insights to the medical community. By leveraging cutting-edge methodologies and fostering partnerships, Ginger Yang aims to bring transformative treatments to market, ultimately enhancing patient care and outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbus, Ohio, United States
Patients applied
Trial Officials
Jingzhen (Ginger) Yang, PhD, MPH
Principal Investigator
Nationwide Children's Hospital - Center for Injury Research and Policy
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials